Company financials and filings can be accessed at the links below.
Innovation Pharmaceuticals (sec.gov)
Latest Filings
December 5, 2023 - 8-K: Current report
November 20, 2023 - 10-Q: Quarterly report for quarter ending September 30, 2023
October 30, 2023 - 8-K: Current report
September 28, 2023 - 10-K: Annual report for year ending June 30, 2023
May 15, 2023 - 10-Q: Quarterly report for quarter ending March 31, 2023
February 15, 2023 - 10-Q: Quarterly report for quarter ending December 31, 2022
November 10, 2022 - 10-Q: Quarterly report for quarter ending September 30, 2022
September 28, 2022 - 10-K: Annual report for year ending June 30, 2022
June 15, 2022 - 8-K: Current report
May 13, 2022 - 10-Q: Quarterly report for quarter ending March 31, 2022
February 14, 2022 - 10-Q: Quarterly report for quarter ending December 31, 2021
November 9, 2021 - 10-Q: Quarterly report for quarter ending September 30, 2021
October 14, 2021 - 8-K: Current report
September 27, 2021 - 10-K: Annual year for year ending June 30, 2021
May 13, 2021 - 10-Q: Quarterly report for quarter ending March 31, 2021
May 3, 2021 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendment
February 22, 2021 - 10-Q: Quarterly report for quarter ending December 31, 2020